Clinical Trials
2 trialsNCT01286675 2019-03-01
Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Completed
NCT01484314 2017-03-15
Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
Dana-Farber Cancer Institute
Phase 2 Terminated